Corcept Therapeutics Incorporated (CORT)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	136,951	107,282	112,634	124,477	128,202
Total assets	US$ in thousands	840,553	621,517	583,430	423,756	571,731
Operating ROA		16.29%	17.26%	19.31%	29.37%	22.42%

December 31, 2024 calculation

Operating ROA = Operating income ÷ Total assets
= $136,951K ÷ $840,553K
= 16.29%

Based on the data provided, Corcept Therapeutics Incorporated's operating return on assets (operating ROA) has fluctuated over the past five years. The operating ROA was 22.42% as of December 31, 2020, showing a strong performance. It increased to 29.37% by December 31, 2021, indicating improved efficiency in generating operating profits from its assets.

However, the trend reversed in the following years as the operating ROA declined to 19.31% by December 31, 2022, and further to 17.26% by December 31, 2023. This downward trend suggests a potential decrease in the company's ability to generate operating income relative to its asset base.

By December 31, 2024, the operating ROA stood at 16.29%, continuing the declining trend observed in the previous years. This may indicate challenges in effectively utilizing the company's assets to generate operating profits.

Overall, while Corcept Therapeutics Incorporated initially demonstrated strong operating ROA, the subsequent decline over the years raises concerns regarding the company's operational efficiency and its ability to generate returns from its assets. Monitoring and analyzing factors impacting the operating ROA will be crucial for understanding the company's financial performance and identifying areas for improvement.